ConductScience.org, home

Paper6371015

Developing new drugs for ovarian cancer: a challenging task in a changing reality.

Canetta RM and 1 other. J Cancer Res Clin Oncol, 1984. Cited by 11 papers, by iCite.

Cite this record

ConductScience Library. Developing new drugs for ovarian cancer: a challenging task in a changing reality. Papers, record 6371015. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6371015

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Developing new drugs for ovarian cancer: a challenging task in a changing reality.
PubMed
Journal
J Cancer Res Clin Oncol
PubMed
Year
1984
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Review
PubMed
Citations, by iCite
11
iCite
Relative citation ratio, by iCite
0.39
iCite
Revised in PubMed
2025-07-19
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Canetta RMR M
2Carter SKS K

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Ovarian NeoplasmsMajor topic
Animals
Cell Line
Clinical Trials as Topic
Combined Modality Therapy
Disease Models, Animal
Drug Evaluation
Drug Evaluation, Preclinical
Female
Humans
Mice
Research Design
Tumor Stem Cell Assay

Source PubMed

Download CSV of topics

References109

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16131277JMS, successor to cisplatin in advanced ovarian carcinoma?Lancet1983https://conductscience.org/library/papers/6131277PubMed
26837681Soft agar colony formation assay for in vitro testing of sensitivity to chemotherapy of gynecologic malignancies.Am J Obstet Gynecol1983https://conductscience.org/library/papers/6837681PubMed
36846245Phase II study of maytansine in the treatment of advanced or recurrent adenocarcinoma of the ovary. A Gynecologic Oncology Group study.Am J Clin Oncol1983https://conductscience.org/library/papers/6846245PubMed
46447099Cyclophosphamide and floxuridine adjuvant chemotherapy for stage III and IV carcinoma of the ovary.Gynecol Oncol1980https://conductscience.org/library/papers/6447099PubMed
57011532Characterization of a murine ovarian reticulum cell sarcoma of histiocytic origin.Cancer Res1981https://conductscience.org/library/papers/7011532PubMed
6329910A phase II clinical trial of prednimustine. Clinical screening cooperative group of E.O.R.T.C.Biomedicine1977https://conductscience.org/library/papers/329910PubMed
7175277Management of ovarian carcinoma. Current concepts and future prospects.N Engl J Med1976https://conductscience.org/library/papers/175277PubMed
87201885Phase II trial of spirogermanium in advanced epithelial carcinoma of the ovary.Cancer Treat Rep1982https://conductscience.org/library/papers/7201885PubMed
96211231Phase II trial of chlorozotocin in malignant melanoma, breast cancer, and other solid tumors.Cancer Treat Rep1982https://conductscience.org/library/papers/6211231PubMed
107200025Response to second line chemotherapy in ovarian cancer of epithelial origin.Eur J Cancer Clin Oncol1981https://conductscience.org/library/papers/7200025PubMed
11404216Second trial drugs in ovarian cancer.Gynecol Oncol1977https://conductscience.org/library/papers/404216PubMed
12626979Kinetics of growth and ectopic production of human chorionic gonadotropin by an ovarian cystadenocarcinoma cell line maintained in vitro.Cancer Res1978https://conductscience.org/library/papers/626979PubMed
137197985Use of high dose cis-dichlorodiammine platinum (II) (NSC--119875) following failure on previous chemotherapy for advanced carcinoma of the ovary.Br J Obstet Gynaecol1981https://conductscience.org/library/papers/7197985PubMed
147195308Update on in vitro testing on new drugs in ovarian cancer and melanoma.Cancer Treat Rep1981https://conductscience.org/library/papers/7195308PubMed
156896260A phase II trial of m-AMSA in the treatment of advanced gynecologic malignancies.Am J Clin Oncol1982https://conductscience.org/library/papers/6896260PubMed
167141920New agents in ovarian cancer.Int J Radiat Oncol Biol Phys1982https://conductscience.org/library/papers/7141920PubMed
176185891Megestrol acetate for the palliation of advanced ovarian carcinoma.Obstet Gynecol1983https://conductscience.org/library/papers/6185891PubMed
18337083[The toxicity of massive dosis of VM26 (4-demethyl-epipodophyllotoxin-beta-D-thenylidene glucoside). A contribution to the therapy of advanced ovarian cancer (author's transl)].Med Klin1977https://conductscience.org/library/papers/337083PubMed
196458544High-dose medroxyprogesterone acetate (MPA) in advanced epithelial ovarian cancer resistant to first- or second-line chemotherapy.Gynecol Oncol1981https://conductscience.org/library/papers/6458544PubMed
206402287The use of intravenous phenylalanine mustard followed by supervoltage irradiation in the treatment of carcinoma of the ovary.Cancer1983https://conductscience.org/library/papers/6402287PubMed

See all 109 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.

PMIDTitleJournalYearIn PapersSource
3583641Activity of tricyclic nucleoside 5'-phosphate in model systems of human ovarian cancer.Invest New Drugs1986https://conductscience.org/library/papers/3583641PubMed
2347051A phase II study of etoposide combined with ifosfamide as second-line therapy in cisplatin-resistant ovarian carcinomas.Cancer Chemother Pharmacol1990https://conductscience.org/library/papers/2347051PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6371015

GET https://conductscience.org/api/papers/v1/6371015/references?page=2